Bertram Pitt
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Renin-Angiotensin System Studies
- Nephrology top 0.05%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Heart Failure Treatment and Management 449
- Acute Myocardial Infarction Research 125
- Blood Pressure and Hypertension Studies 83
- Cardiovascular Function and Risk Factors 46
-
- Hormonal Regulation and Hypertension 112
- Co-authors
- Faiez M. Zannad (223 shared papers)Willem J. Remme (7 shared papers)A.J. Pérez Pérez (3 shared papers)Robert J Cody (4 shared papers)Jolie Palensky (2 shared papers)A Castaigne (2 shared papers)H. William Strausś (43 shared papers)Janet Wittes (1 shared paper)
- Journals
- Journal of the American College of Cardiology (103 papers)The American Journal of Cardiology (94 papers)European Journal of Heart Failure (91 papers)Circulation (84 papers)European Heart Journal (53 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Bertram Pitt
1k papers receiving 84.6k citations
Bertram Pitt's Hit Papers
Peers
Comparison fields: 5 of 189
- Cardiology and Cardiovascular Medicine 55.1k
- Nephrology 8.6k
- Endocrinology, Diabetes and Metabolism 13.6k
- Radiology, Nuclear Medicine and Imaging 6.1k
- Pulmonary and Respiratory Medicine 5.8k
Countries citing papers authored by Bertram Pitt
This map shows the geographic impact of Bertram Pitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertram Pitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertram Pitt more than expected).
Fields of papers citing papers by Bertram Pitt
This network shows the impact of papers produced by Bertram Pitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertram Pitt. The network helps show where Bertram Pitt may publish in the future.
Co-authors
The 25 scholars most cited alongside Bertram Pitt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.1k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Hit paper breakdown → | 1999 | 7258 |
| 2 | Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction Hit paper breakdown → | 2003 | 3935 |
| 3 | The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure Hit paper breakdown → | 2000 | 2578 |
| 4 | Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms Hit paper breakdown → | 2010 | 2466 |
| 5 | Spironolactone for Heart Failure with Preserved Ejection Fraction Hit paper breakdown → | 2014 | 2201 |
| 6 | Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes Hit paper breakdown → | 2020 | 1987 |
| 7 | The Seattle Heart Failure Model Hit paper breakdown → | 2006 | 1702 |
| 8 | Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients Hit paper breakdown → | 2008 | 1562 |
| 9 | Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II Hit paper breakdown → | 2000 | 1487 |
| 10 | Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure Hit paper breakdown → | 2020 | 1452 |
| 11 | Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) Hit paper breakdown → | 1997 | 1334 |
| 12 | Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes Hit paper breakdown → | 2021 | 1177 |
| 13 | Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction Hit paper breakdown → | 1996 | 1075 |
| 14 | Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2020 | 944 |
| 15 | Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease Hit paper breakdown → | 1996 | 885 |
| 16 | Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial Hit paper breakdown → | 2014 | 870 |
| 17 | Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis Hit paper breakdown → | 2021 | 834 |
| 18 | Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure Hit paper breakdown → | 2000 | 810 |
| 19 | A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction Hit paper breakdown → | 1987 | 760 |
| 20 | Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis Hit paper breakdown → | 2021 | 749 |
About Bertram Pitt
Bertram Pitt is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 1.1k papers that have together received 92.7k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (449 papers), Acute Myocardial Infarction Research (125 papers), Hormonal Regulation and Hypertension (112 papers), Cardiac Imaging and Diagnostics (101 papers), Chronic Kidney Disease and Diabetes (100 papers), Blood Pressure and Hypertension Studies (83 papers), Potassium and Related Disorders (78 papers) and Cardiovascular Function and Risk Factors (46 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (55.1k citations), Nephrology (8.6k citations), Endocrinology, Diabetes and Metabolism (13.6k citations), Radiology, Nuclear Medicine and Imaging (6.1k citations) and Pulmonary and Respiratory Medicine (5.8k citations). Bertram Pitt has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Faiez M. Zannad, Willem J. Remme, A.J. Pérez Pérez, Robert J Cody, Jolie Palensky, A Castaigne, H. William Strausś, Janet Wittes, Stefan D. Anker and Felipe A. Martínez. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Cardiology, European Journal of Heart Failure, Circulation and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.